Reo Fukuda

Reo Fukuda

Auto-generated profile, based on publicly available information

Reo Fukuda

Emergency and Critical Care Center, Nippon Medical School Tama- Nagayama Hospital, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2015 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
TITakayuki Irahara
Takayuki Irahara
NSNorio Sato
Norio Sato
YMYuuta Moroe
Yuuta Moroe
RFReo Fukuda
Reo Fukuda
YIYusuke Iwai
Yusuke Iwai
KUKyoko Unemoto
Kyoko Unemoto
Intra-aortic balloon occlusion (IABO) is useful for proximal vascular control, by clamping the descending aorta, in traumatic haemorrhagic shock. However, there are limited clinical studies regarding its effectiveness. This study aimed at investigating the effectiveness of IABO for traumatic haemorrhagic shock. This retrospective, observational study included trauma patients who underwent IABO at the Emergency and Critical Care Center of Nippon Medical School Tama-Nagayama Hospital between January 2009 and March 2013. 14 patients were included to this study who were in shock on arrival (systolic blood pressure [SBP] <90 mmHg or shock index ≥1), underwent IABO for resuscitation and temporary haemostasis, and subsequently underwent haemostatic intervention (operation or transcatheter arterial embolization). Patient characteristics, physiological status, SBP, heart rate (HR), initial fluid and blood transfusion, time course, and total occlusion time were compared before and after IABO as well as between the survived (n = 5) and non-survived (n = 9) groups. The majority of patients experienced blunt injuries, with an average injury severity score of 29.5. The liver, pelvis, spleen, and mesenterium represented the majority of injured organs. SBP, but not HR, was significantly higher after IABO than before IABO (123.1 vs. 65.5 mmHg, P = 0.0001). The revised trauma score and probability of survival were significantly different between the survived and non-survived groups (both, P = 0.04). The survived group required significantly less blood transfusion volume than the non-survived group (20 vs. 33.7 red blood cell units, P = 0.04). In addition, the survived group required a significantly shorter total occlusion time than the non-survived group (46.2 vs. 224.1 min, P = 0.002). IABO was used for relatively severe trauma patients. SBP was significantly higher after IABO, but was not related to survival. However, blood transfusion volume and total occlusion time were related to survival; therefore, it is important to reduce or shorten these parameters, i.e., immediate definitive haemostasis. IABO is effective for traumatic haemorrhagic shock; however, it is also important to consider these points and potential complications.

19 October 2026 in Injury
Verified
Journal Article
Open access
CTChie Tanaka
Chie Tanaka
TTTakashi Tagami
Takashi Tagami
RFReo Fukuda
Reo Fukuda
TSTaigo Sakamoto
Taigo Sakamoto
FNFumihiko Nakayama
Fumihiko Nakayama
MKMasamune Kuno
Masamune Kuno
Severe trauma patients often need a large amount of blood transfusion including red blood cells (RBCs), fresh frozen plasma (FFP) and platelet. The blood transfusion can cause serious transfusion-related adverse events including respiratory complications, however, the risks of blood transfusion in trauma patients have not been well documented. We evaluated the hypothesis that the amount of blood transfusion during the acute post-injury phase was associated with respiratory failure among severe trauma patients at risk of active bleeding using a database of a randomized multicenter trial. We used data from the Restrictive Transfusion Strategy for Critically Injured Patients (RESTRIC) trial, a cluster-randomized, crossover, non-inferiority multicenter trial conducted in Japan from May 7, 2019 to October 31, 2021 in Japan. The trial enrolled adult trauma patients transferred to the emergency department with severe bleeding or suspected severe bleeding and circulatory shock. All patients registered in this trial were included in this study. The primary outcome measure was the occurrence of respiratory failure within 7 days after admission. A logistic regression analysis on respiratory failure adjusted for sex, Injury Severity Score (ISS), chest Abbreviated Injury Scale (AIS) score, and the amount of RBCs, FFP, and platelet transfusions within 24 h was performed. Of 417 trauma patients, 40 (9.8%) developed respiratory failure. Logistic regression analysis revealed that sex, chest AIS score, and platelet transfusion volume were associated with respiratory failure with 7 days after admission after adjustment (odds ratio [OR]: 0.300, 95% confidence interval [CI]: 0.113-0.794, p = 0.015, OR: 1.732, 95% CI: 1.267-2.367, p < 0.001, OR: 1.071, 95% CI: 1.021-1.122, p = 0.005 respectively). ISS, RBC, and FFP transfusions were not associated with respiratory failure (all p ≥ 0.05). Among severe trauma patients with severe bleeding or circulatory shock transferred to the emergency department, platelet transfusion volume within 24 h may be a risk factor for respiratory failure within 7 days after admission. In contrast, RBC and FFP transfusions were not associated with respiratory failure.